Ibrahim Halil Sahin, MD, and colleagues, explore, the CIRCULATE-US (NRG-GI008; NCT05174169) investigating postoperative ctDNA dynamics in early-stage colon cancer for treatment selection.
Yan Lin, PhD
Advertisement
Articles by Yan Lin, PhD
Advertisement
Latest Updated Articles
Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-USPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Adjuvant Cemiplimab in Cutaneous Squamous Cell Carcinoma
2
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
3
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
4
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
5
